| 
                                DNA baskets for the targeted delivery of siRNA   
                              
                                Amanda Zirzow, MIkhail Skoblov, Andre Marakhonov, Maria Emelianenko, Alexandre Vetcher, Vikas Chandhoke, Zobair M. Younossi  
                                This is a collaborative project between 
                                 Molecular and Microbiology Department, College  of Science,George  Mason University,  Fairfax, VA 
                                Research Center for Medical Genetics, RAMS,  Moscow 
                                Department of Mathematics, College  of Science, George  Mason University,  Fairfax, VA 
                                                             
                              The paper describing the basics of this technology has been recently accepted to International Journal of Nano and Biomaterials (IJNBM) 
                              Silencing of gene expression by siRNA holds a promise both for a 
                                drug target discovery and as a therapy. Major bottlenecks of siRNA technology 
                                include ‘off-target’ silencing effects and problems with siRNA degradation 
                                before delivery. We propose a two-fold approach aimed at curtailing described 
                                shortcomings. First, before pre-clinical tests each siRNA shall be matched to 
                                comprehensive redundancy minimiser (CRM) curated database that contain 
                                comprehensively mapped all unique sequences (‘targets’) 9 nt to 15 nt in size 
                                within human transcriptome. Second, we propose to deliver siRNA within 
                                DNA-wrapped RNA-containing nanoparticle formed by partial dsRNA-DNA 
                                triplex. The DNA core will be chemically modified to promote triplex 
                                formation/folding. In these binary nanoparticles, DNA will serve as the 
                                biodegradable ‘basket’ that could be custom designed in order to enhance its 
                                interaction with the particular siRNA duplex. We also propose to covalently 
                                bind DNA basket to targeting peptides ensuring addressed delivery of the 
                                therapeutic nanoparticle. 
                              Figure 1. ‘DNA baskets’ for siRNA delivery. (A) simplest implementation of the biodegradable 
                                DNA baskets slowing down the kinetics of the degradation of siRNA (B) targeting of 
                                the DNA basket to the tissue of interest may be achieved by the crosslinking of DNA 
                                with various proteins and protein fragments affine to the surface receptors of the target 
                                cells (C) branching DNA structures stably locked at physiological temperatures are 
                                sterically capable of encapsulating siRNA molecules (D) parts of the DNA molecules 
                                within DNA-siRNA nanoparticles could be engineered to form dsRNA-DNA triplexes. 
                              
                                  
                                |